SOYBEAN AND HEALTH - University of Macau Library

More documents

Recommendations

Info

418Soybean and HealthIndices Groups Initial Values After 1 month After 2 monthsTotal Cholesterol(mg/dl)HDL-Cholesterol(mg/dL)Non HDL-Cholesterol(mg/dL)Triglycerides(mg/dL)Glucose(mg/dL)Total protein(g/L)GOT(U/L)GPT(U/L)SPI 280±7 281±10 263±9**SMP 277±9 282±10 272±9SPI 57.4±2.5 60.2 ±2.6 62.5±2.9***SMP 59.3±3.3 60.1±2.4 56.6±2.6SPI 223±7 221±10 201±8.8***SMP 219±10 222±10 215±9SPI 204±23 183.3±2* 173±16*SMP 192±17 193±20 201±17SPI 85.8±4.7 83.4±3.0 79.0±3*SMP 87.8±5.5 86.1±4.8 88.6±3.6SPI 78.0±1.0 78.3±0.8 78.9±0.8SMP 76.2±0.8 78.0±0.7 77.6±1.1SPI 22.1±2.4 20.8±1.7 22.2±2.1SMP 17.2±1.4 20.7±1.4 18.9±1.7SPI 22.6±3.1 18.3±2.6 21.1±1.9SMP 16.5±1.7 16.4±1.7 18.9±1.9Table 8. Serum lipid and glucose concentrations and GOT and GPT activities at thebeginning and after 1 and 2 months of the dietary treatments (from Borodin et al., 2009).Values are means ± SEM. Total number of participants in each pooled group is 28. * - p
Antioxidant and Hypocholesterolemic Effects of Soy Foods and Cardiovascular Disease 419mentioned above might have been the poor acceptability and poor sustainability of SPI tothe subjects. SPI at 30 g a day may be easy for Asians to accept but not for Westerners andRussians. For this reason, we developed well-accepted test-foods with a high SPI content.The intakes of energy, proteins, fats and carbohydrates were similar at all periods of study:in the initial period, during the first and second months and at the washout period, whichmay also mean that the cookies were well accepted. The third reason for the favorableresults may be the level of hyperlipidemia in our subjects. As reviewed by Anderson et al.(1) the cholesterol-lowering effect of SPI was observed more clearly in subjects with highserum Total- and LDL-cholesterol concentrations than in those with normal and low lipidconcentrations. Our inclusion criteria were overweight (BMI 25-34 kg/m 2 ), fasting serumtotal cholesterol 240-330 mg/dL, non-HDL-cholesterol 150-280 mg/dL; HDL-Cholesterol 40-70 mg/dL, triglycerides 100-280 mg/dL.ConclusionConsumption of the low-energy SPI-enriched cookies (30 g of SPI a day) for 2 months with acrossover design confirmed the favorable effects of SPI on serum lipids in Russians withmoderate hyperlipidemia.4. CVD, soy and soy foods in RussiaIn the 90-th of the last century the situation with the health of Russian people drasticallydeteriorated and CVD had became the main reason of mortality. Above we discussed theantioxidant and hypocholesterolemic effects of soy foods and our personal results, showingthe effectiveness of soy foods in the decreasing of blood cholesterol in Russians withmoderate hyperlipidemia. In the last part we will focus attention on the epidemiology ofCVD in modern Russia, dietary habits and lifestyle of Russians, which predispose highmortality rate from CVD, and on the possibility of use of soy foods for the prevention andtreatment of CVD in Russia.4.1 Epidemiology of CVD in RussiaAn epidemiologic feature of the present Russia is the high mortality rate from CVD.According to the WHO Statistical Information System Mortality Database, the mortality rateper 100,000 from CVD in Russian adults under 65 years increased from 141-161 in 1986-1991to 233-251 in 2001-2005 (WHO Statistical Information System Mortality Database). The rateswere similar to those in the USA (241.8 and 244.4 for males and females, respectively) andEngland (263 and 235) and higher than those in Japan (136 and 138) and France (172 and176) (WHO Statistical Information System Mortality Database). The average lifespans ofRussians in late 1990s were only 58 years for males and 72 for females, while they were 79and 86 for Japanese, 75 and 80 for Americans, and 77 and 81 for French individuals (UNDemographic Yearbook 2004). The dietary habits and lifestyle of Russians, namely highconsumption of saturated fats (Solodkaia et al., 1998) and abuse of alcohol (Leon et al., 2007),associated with excessive body mass (Konstantinov et al., 2002), predispose individuals toshort longevity as a result of a high mortality rate, especially from CVDs (Kharchenko et al.,1997), which is characteristic for the present-day Russians. Therefore, soy foods may behelpful for Russians in the prevention of CVD. Due to climate conditions, Russia is able toproduce abundant soybeans but the consumption of soy foods by Russians is very limited
Page 3:
free online editions of InTechBooks
Page 9:
PrefaceWorldwide, soybean seed prot
Page 13 and 14:
Soybean Products Consumption in the
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21:
Page 25 and 26:
Page 27:
Page 30 and 31:
20Soybean and HealthWagner, J.D., A
Page 32 and 33:
22Soybean and HealthDifferences in
Page 34 and 35:
24Soybean and Healthfermented chung
Page 36 and 37:
26Soybean and HealthIsoflavones, wh
Page 38 and 39:
28Soybean and HealthThe concentrati
Page 40 and 41:
30Soybean and Health5. Metabolite p
Page 42 and 43:
32Soybean and Healththat various me
Page 44 and 45:
34Soybean and Healtheffects on hypo
Page 46 and 47:
36Soybean and Healthfatty acid oxid
Page 48 and 49:
38Soybean and HealthThe decreased n
Page 50 and 51:
40Soybean and Healththe N-terminus
Page 52 and 53:
42Soybean and HealthYAVE, IVAE, LVA
Page 54 and 55:
44Soybean and Healthrespectively, w
Page 56 and 57:
46Soybean and HealthIn order to des
Page 58 and 59:
48Soybean and Healthpeptides that w
Page 60 and 61:
50Soybean and Healthreactions, new
Page 62 and 63:
52Soybean and HealthGibbs, B.F.; Zo
Page 64 and 65:
54Soybean and HealthKoo, B.; Seong,
Page 66 and 67:
56Soybean and HealthPak, V.V.; Koo,
Page 68 and 69:
58Soybean and HealthBalance between
Page 70 and 71:
60Soybean and HealthAll results are
Page 72 and 73:
62Soybean and Healthfrom 10.01 ± 1
Page 74 and 75:
64Soybean and Healthmeasured in eac
Page 76 and 77:
66Soybean and HealthFig. 2. Time co
Page 78 and 79:
68Soybean and Healthω3D rats switc
Page 80 and 81:
70Soybean and Health3.4.4 Monodesat
Page 82 and 83:
72Soybean and Healthpercentages yie
Page 84 and 85:
74Soybean and Healthinstance, such
Page 86 and 87:
76Soybean and Healthconcerned the c
Page 88 and 89:
78Soybean and HealthMalaisse, W.J.
Page 90 and 91:
80Soybean and Healthflavonoids show
Page 92 and 93:
82Soybean and HealthSupplies (Poole
Page 94 and 95:
84Soybean and Healthal., 2004). For
Page 96 and 97:
86Soybean and HealthABFig. 1. IBD p
Page 98:
88Soybean and Healthdamage for both
Page 101 and 102:
The Effect of Flavonoids in Soybean
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Effects of Dietary Soybean Trypsin
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Conjugated Linoleic Acid: A Milk Fa
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Lunasin, a Cancer Preventive Seed P
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Insights into the Pharmacological E
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
9Occurrence of Biogenic Aminesin So
Page 193 and 194:
Occurrence of Biogenic Amines in So
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
10Biologically Active Molecules fro
Page 219 and 220:
Biologically Active Molecules from
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
11From Soybean Phytosterolsto Stero
Page 243 and 244:
From Soybean Phytosterols to Steroi
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
12Genistein Derivatization - From a
Page 265 and 266:
Genistein Derivatization - From a D
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
13Soybean Oil: Production Process,
Page 295 and 296:
Soybean Oil: Production Process, Be
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Page 313 and 314:
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321 and 322:
14Beneficial Effects of Bioactive P
Page 323 and 324:
Beneficial Effects of Bioactive Pep
Page 325 and 326:
Page 327 and 328:
Page 329 and 330:
Page 331 and 332:
Page 333 and 334:
Page 335 and 336:
Page 337 and 338:
Page 339 and 340:
15Soy Isoflavones as BioactiveIngre
Page 341 and 342:
Soy Isoflavones as Bioactive Ingred
Page 343 and 344:
Page 345 and 346:
Page 347 and 348:
Page 349 and 350:
Page 351 and 352:
Page 353 and 354:
Page 355 and 356:
Page 357 and 358:
Page 359 and 360:
Page 361 and 362:
Page 363 and 364:
Page 365 and 366:
Page 367 and 368:
Page 369 and 370:
Page 371 and 372:
16Soybean Oil: How Good or How Bad
Page 373 and 374:
Soybean Oil: How Good or HowBad in
Page 375 and 376:
Soybean Oil: How Good or HowBad in
Page 377 and 378: Soybean Oil: How Good or HowBad in
Page 393 and 394: 17Anti-Diarrhoeal Aspectsof Ferment
Page 395 and 396: Anti-Diarrhoeal Aspects of Fermente
Page 417 and 418: 18Antioxidant and Hypocholesterolem
Page 419 and 420: Antioxidant and Hypocholesterolemic
Page 427: Antioxidant and Hypocholesterolemic
Page 435 and 436: 19Important Minor Soybens Proteins:
Page 437 and 438: Important Minor Soybens Proteins: S
Page 443 and 444: 20Soybean Allergens: Presence, Dete
Page 445 and 446: Soybean Allergens: Presence, Detect
Page 475 and 476: 21Nutritional and Bioactive Compoun
Page 477 and 478: Nutritional and Bioactive Compounds
Page 479 and 480:
Nutritional and Bioactive Compounds
Page 481 and 482:
Page 483 and 484:
Page 485 and 486:
Page 487 and 488:
Page 489 and 490:
Page 491 and 492:
Page 493 and 494:
Page 495 and 496:
Page 497 and 498:
Page 499 and 500:
22Polyamines - The Principal Candid
Page 501 and 502:
Polyamines - The Principal Candidat
Page 503 and 504:
Page 505 and 506:
Page 507 and 508:
Page 509 and 510:
Page 511 and 512:
show all

SOYBEAN AND HEALTH - University of Macau Library

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?